SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.205-2.8%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: HardToFind who wrote (12443)11/19/2019 6:14:59 PM
From: old 'n cranky  Read Replies (1) of 12873
 
Funny stuff, but I think we read that excerpt differently.

On September 27, the Company filed a Form S-1 public offering with the SEC, that it withdrew on November 5, after the Board of Directors determined that the proposed terms of equity-plus-warrants based offering were not in the best interests of the shareholders.

Your comment ....
After performing due diligence, ummmm...we changed our minds. Not interested...no, not even a little.
......suggests to me that by "the shareholders" you feel they meant the new investors. I believe they were trying to provide an excuse for the abandonment and were actually referring to EXISTING shareholders, as in "On second thought we decided that the terms might be too damaging to the fine folks who already hold our shares".
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News